Kopran Limited (BOM:524280)

Market Cap	5.88B -28.1%
Revenue (ttm)	6.20B -3.7%
Net Income	165.43M -65.2%
EPS	3.42 -65.3%
Shares Out	48.29M
PE Ratio	35.68
Forward PE	n/a
Dividend	3.00 (2.46%)
Ex-Dividend Date	Sep 4, 2025

Volume	81,531
Average Volume	26,363
Open	115.20
Previous Close	121.85
Day's Range	113.00 - 121.80
52-Week Range	110.90 - 214.65
Beta	0.29
RSI	48.21
Earnings Date	May 15, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.